Several cancer drug candidates in clinical trials are designed to kill tumor cells by attacking certain targets, but they actually work in other ways, a study by Cold Spring Harbor Laboratory has found.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,